PTHLH and prostate cancer: As EMT has been shown previously to induce cancer stem cell properties [18], it follows that PTHrP should potentially be able to regulate stem cell properties in prostate cancer and thus may be a valuable therapeutic target for preventing recurrence and metastasis.